Radiologists use diagnostic imaging to non-invasively look inside the body to help determine the causes of an injury or an illness, and confirm a diagnosis. Providers use many imaging modalities to do so, including CT, MRI, X-ray, Ultrasound, PET and more.
This is a clinical photo gallery of fetal imaging that explains what all can be seen on medical imaging, how sex is determined, how measurements are used to track the development of a baby.
Not only could the materials reduce patient exposure to ionizing radiation, they also could reduce costs associated with traditional X-ray equipment, according to newly published research in Nature Communications.
Experts from Mayo Clinic recently detailed their experience with the new offering, sharing that out of their 10 top ranked candidates, six had signaled the program.
Features pertaining to location, density and superimposed structures were recently found to be associated with poorer outcomes for patients who initially had their lung cancer overlooked on radiographs.
The Australia-based company made the announcement on April 12 in a release that described the timing of these AI-assisted solutions as “increasingly important” amid growing workloads and staffing shortages.
Radiologists used an AI tool-building platform to create their model(s), which allows clinicians the opportunity to develop AI models without any prior training in data sciences or computer programming.
The tool’s sensitivity was recorded as 99.1% for abnormal radiographs and 99.8% for critical radiographs—better than two board-certified radiologists who also interpreted the exams.
The American Society of Echocardiography released a new guideline document on the comprehensive use of echocardiography in the diagnosis and therapeutic intervention of rheumatic heart disease.
GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview.
Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.